Abstract
Brain-specific angiogenesis inhibitor 1 (BAI1) encodes a seven-transmembrane protein that belongs to the adhesion-GPCR family.1–7 Although BAI1 was named for the ability of its extracellular region to inhibit angiogenesis in tumor models, its function in physiological contexts was elusive and remained an orphan receptor until recently.5,6,8–14 BAI1 is now considered a phagocytic receptor that can recognize phosphatidylserine exposed on apoptotic cells. Moreover, BAI1 has been shown to function upstream of the signaling module comprised of ELMO/Dock180/Rac proteins, thereby facilitating the cytoskeletal reorganization necessary to mediate the phagocytic clearance of apoptotic cells.15,16 Here,wereview the phytogeny, structure, associating proteins, as well as the known and proposed functions of BAI1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kee HJ, Ahn KY, Choi KC et al. Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma. FEBS Lett 2004; 569(1-3):307–316.
Kaur B, Brat DJ, Calkins CC et al. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. Am J Pathol 2003; 162(1):19–27.
Mori K, Kanemura Y, Fujikawa H et al. Brain-specific angiogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells. Neurosci Res 2002; 43(1):69–74.
Yoshida Y, Oshika Y, Fukushima Y et al. Expression of angiostatic factors in colorectal cancer. Int J Oncol 1999; 15(6):1221–1225.
Fukushima Y, Oshika Y, Tsuchida T et al. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol 1998; 13(5):967–970.
Nishimori H, Shiratsuchi T, Urano T et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997; 15(18):2145–2150.
Shiratsuchi T, Nishimori H, Ichise H et al. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1). Cytogenet Cell Genet 1997; 79(1-2): 103–108.
Kaur B, Cork SM, Sandberg EM et al. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis througha CD36-dependent mechanism. Cancer Res 2009; 69(3):1212–1220.
Kudo S, Konda R, Obara W et al. Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma. Oncol Rep 2007; 18(4):785–791.
Kang X, Xiao X, Harata M et al. Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas. Cancer Gene Ther 2006; 13(4):385–392.
Kaur B, Brat DJ, Devi NS et al. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 2005; 24(22):3632–3642.
Yoon KC, Ahn KY, Lee JH et al. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Gene Ther 2005; 12(7):617–624.
Koh JT, Kook H, Kee HJ et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin. Exp Cell Res 2004; 294(1):172–184.
Hatanaka H, Oshika Y, Abe Y et al. Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1). Int J Mol Med 2000; 5(2):181–183.
Park D, Hochreiter-Hufford A, Ravichandran KS. The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr Biol 2009; 19(4):346–351.
Park D, Tosello-Trampont AC, Elliott MR et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007; 450(7168):430–434.
Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009; 459(7245):356–363.
Fredriksson R, Lagerstrom MC, Lundin LG et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups and fingerprints. Mol Pharmacol 2003; 63(6):1256–1272.
Klabunde T, Hessler G. Drug design strategies for targeting G-protein-coupled receptors. Chembiochem 2002; 3(10):928–944.
Bjarnadottir TK, Fredriksson R, Hoglund PJ et al. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics 2004; 84(1):23–33.
Haitina T, Olsson F, Stephansson O et al. Expression profile of the entire family of Adhesion G protein-coupled receptors in mouse and rat. BMC Neurosci 2008; 9:43.
Yona S, Lin HH, Siu WO et al. Adhesion-GPCRs: emerging roles for novel receptors. Trends Biochem Sci 2008; 33(10):491–500.
Bjarnadottir TK, Fredriksson R, Schioth HB. The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci 2007; 64(16):2104–2119.
Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 1986; 103(5):1635–1648.
Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol 2000; 19(7):597–614.
Silverstein RL. The face of TSR revealed: an extracellular signaling domain is exposed. J Cell Biol 2002; 159(2):203–206.
Manodori AB, Barabino GA, Lubin BH et al. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 2000; 95(4):1293–1300.
Adams JC, Tucker RP. The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development. Dev Dyn 2000; 218(2):280–299.
Huwiler KG, Vestling MM, Annis DS et al. Biophysical characterization, including disulfide bond assignments, of the anti-angiogenic type 1 domains of human thrombospondin-1. Biochemistry 2002; 41(48):14329–14339.
Smith KF, Nolan KF, Reid KB et al. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat. Biochemistry 1991; 30(32):8000–8008.
Harmar AJ. Family-B G-protein-coupled receptors. Genome Biol 2001; 2(12):REVIEWS3013.
Shiratsuchi T, Futamura M, Oda K et al. Cloning and characterization of BAI-associated protein 1: a PDZ domain-containing protein that interacts with BAI1. Biochem Biophys Res Commun 1998; 247(3):597–604.
Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007; 7(12):964–974.
Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. J Cell Biol 1059; 189(7):1059–1070.
Elliott MR, Zheng S, Park D et al. Unexpected requirement for ELMO1 in apoptotic germ cell clearance in vivo. Nature 2010; In Press.
Park D, Tosello-Trampont AC, Elliott MR et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007; 450:430–434.
Lu M, Ravichandran KS. Dock180-ELMO cooperation in Rac activation. Methods Enzymol 2006; 406:388–402.
Lu M, Kinchen JM, Rossman KL et al. A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs. Curr Biol 2005; 15(4):371–377.
Lu M, Kinchen JM, Rossman KL et al. PH domain of ELMO functions in trans to regulate Rac activation via Dock180. Nat Struct Mol Biol 2004; 11(8):756–762.
Grimsley CM, Kinchen JM, Tosello-Trampont AC et al. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem 2004; 279(7):6087–6097.
Brugnera E, Haney L, Grimsley C et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 2002; 4(8):574–582.
Gumienny TL, Brugnera E, Tosello-Trampont AC et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001; 107(1):27–41.
Anderson JC, McFarland BC, Gladson CL. New molecular targets in angiogenic vessels of glioblastoma tumours. Expert Rev Mol Med 2008; 10:e23.
Kleihues P, Louis DN, Scheithauer BW et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61(3):215–225; discussion 226–219.
Duda DG, Sunamura M, Lozonschi L et al. Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. Br J Cancer 2002; 86(3):490–496.
Cao Y, Nagesh V, Hamstra D et al. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 2006; 66(17):8912–8917.
Muccio CF, Esposito G, Bartolini A et al. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med 2008; 113(5):747–757.
Ray SK, Patel SJ, Welsh CT et al. Molecular evidence of apoptotic death inmalignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res 2002; 69(2):197–206.
Sinha S, Bastin ME, Whittle IR et al. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002; 23(4):520–527.
Fujiwara T, Mammoto A, Kim Y et al. Rho small G-protein-dependent binding of mDia to an Src homology 3 domain-containing IRSp53/BAIAP2. Biochem Biophys Res Commun 2000; 271(3):626–629.
Kim MY, Ahn KY, Lee SM et al. The promoter of brain-specific angiogenesis inhibitor 1-associated protein 4 drives developmentally targeted transgene expression mainly in adult cerebral cortex and hippocampus. FEBS Lett 2004; 566(1-3):87–94.
Oda K, Shiratsuchi T, Nishimori H et al. Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1. Cytogenet Cell Genet 1999; 84(1-2):75–82.
Shiratsuchi T, Oda K, Nishimori H et al. Cloning and characterization of BAP3 (BAI-associatedprotein 3), a C2 domain-containingproteinthat interacts with BAI1. Biochem Biophys Res Commun 1998; 251(1):158–165.
Koh JT, Lee ZH, Ahn KY et al. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein. Brain Res Mol Brain Res 2001; 87(2):223–237.
Funke L, Dakoji S, Bredt DS. Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions. Annu Rev Biochem 2005; 74:219–245.
Gonzalez-Mariscal L, Betanzos A, Avila-Flores A. MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 2000; 11(4):315–324.
Krugmann S, Jordens I, Gevaert K et al. Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex. Curr Biol 2001; 11(21):1645–1655.
Miki H, Yamaguchi H, Suetsugu S et al. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 2000; 408(6813):732–735.
Takenawa T, Miki H. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci 2001; 114(Pt 10): 1801–1809.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Park, D., Ravichandran, K.S. (2010). Emerging Roles of Brain-Specific Angiogenesis Inhibitor 1. In: Yona, S., Stacey, M. (eds) Adhesion-GPCRs. Advances in Experimental Medicine and Biology, vol 706. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7913-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7913-1_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7912-4
Online ISBN: 978-1-4419-7913-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)